The Sievers Eclipse is an innovative platform that decreases assay setup time by up to 85% and reduces Limulus Amebocyte Lysate (LAL) reagent use by up to 90% while meeting all requirements of the harmonized pharmacopoeia (EP 2.6.14, USP <85> and JP 4.01). Through groundbreaking technology, the Eclipse platform significantly decreases pipetting steps, reduces operator-to-operator variability, and simplifies assay setup. The Eclipse BET platform leverages precise microfluidic liquid handling and embedded endotoxin in order to automate kinetic chromogenic assays. Throughput of 21 samples per plate is maintained without the complexity of robotics or the time and technique demands of a traditional assay.
Sievers Eclipse Bacterial Endotoxins Testing (BET) Platform
